tiprankstipranks
Decoy Therapeutics (DCOY)
NASDAQ:DCOY
US Market
Want to see DCOY full AI Analyst Report?

Decoy Therapeutics (DCOY) Ownership - Who Owns Decoy Therapeutics?

640 Followers

Decoy Therapeutics (DCOY) Ownership Overview

10.49%0.62%88.89%
10.49% Insiders
0.62% ETFs
88.89% Public Companies and
Individual Investors
The ownership structure of Decoy Therapeutics (DCOY) stock is a mix of institutional, retail, and individual investors. , 10.49% is owned by Insiders, and 88.89% is owned by Public Companies and Individual Investors.
The ownership structure of Decoy Therapeutics (DCOY) stock is a mix of institutional, retail, and individual investors. Approximately 89.51% of the company’s stock is owned by Institutional Investors, 10.49% is owned by Insiders

Recent Insider Trading Activity

Date
Name
Activity
Value
Jan 02, 2026
xxxxxxxxxxxxx
$17
Nov 24, 2025
xxxxxxxxxxxxx
$3700
Nov 20, 2025
xxxxxxxxxxxxx
$16000

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
34,844Insider5.32%93,730
11,363Insider1.73%30,566
4,216Insider0.64%11,341
4,034Institution0.62%10,851
3,900Insider0.60%10,491
3,418Insider0.52%9,194
3,002Insider0.46%8,075
2,002Insider0.31%5,385
2,002Insider0.31%5,385
2,001Insider0.31%5,383

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
4,034Institution0.62%16,580
19Institution<0.01%57

FAQ

Who Owns Decoy Therapeutics (DCOY)?
Currently, no data Available
What percentage of Decoy Therapeutics (DCOY) stock is held by institutional investors?
Currently, no data Available
What percentage of Decoy Therapeutics (DCOY) stock is held by retail investors?
According to the latest TipRanks data, approximately 88.89% of Decoy Therapeutics (DCOY) stock is held by retail investors.
    Who owns the most shares of Decoy Therapeutics (DCOY)?
    FREDERICK II PIERCE owns the most shares of Decoy Therapeutics (DCOY).
      What is the significance of the ownership structure for a publicly traded company?
      The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.